1 Result(s)

Article

T cells, particularly activated CD4⁺ cells, maintain anti-CD20-mediated NK cell viability and antibody dependent cellular cytotoxicity

Anti-CD20 monoclonal antibody (mAb) therapy is a mainstay of therapy for B cell malignancies, however many patients fail to respond or eventually develop resistance. The current understanding of mechanisms res...

Zhaoming Wang, Michael S. Chimenti, Christopher Strouse… in Cancer Immunology, Immunotherapy (2022)